Interventional therapy for liver metastases;Interventionelle therapie von lebermetastasen

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 11, 2004, Pages 1321-1328

  Ricke, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemotherapy; Interventions; Liver metastases; Tumour ablation

Indexed keywords

ANTINEOPLASTIC AGENT;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPERTHERMIC THERAPY; INTERVENTIONAL RADIOLOGY; LIVER METASTASIS; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME; VASCULAR ACCESS;

COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; RADIOLOGY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 10644246075     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813784     Document Type: Review

References (67)

1. Tacke J, Adam G, Speetzen R et al. MR-guided interstitial cryotherapy of the liver with a novel, nitrogen-cooled cryoprobe. Magn Reson Med 1998; 39 (3): 354-360
2. Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound, surgery of the future? Br J Radiol 2003; 76 (909): 590-599
3. Shiina S, Tagawa K, Unuma T et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991; 68 (7): 1524-1530
4. Seki T, Wakabayashi M, Nakagawa T et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma, comparison with percutaneous ethanol injection therapy. Cancer 1999; 85 (8): 1694-1702
5. Rossi S, Fornari F, Pathies C et al. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990; 76: 54-57
6. Pereira PL, Trubenbach J, Schmidt D. Radiofrequency ablation, basic principles, techniques and challenges. Fortschr Rontgenstr 2003; 175 (1): 20-27
7. Jung EM, Clevert DA, Rupp N. Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors. Fortschr Rontgenstr 2003; 175 (10): 1403-1412
8. Stroszczynski C, Gretschel S, Gaffke G et al. Laser-induced thermotherapy (LITT) for malignant liver tumours, the role of sonography in catheter placement and observation of the therapeutic procedure. Ultraschall Med 2002; 23 (3): 163-167
9. Pech M, Werk M, Beck A et al. Systemkonstanz und Energieverteilung bei Laser-induzierter interstitieller Thermotherapie (LITT). Fortschr Rontgenstr 2002; 174 (6): 754-760
10. Solbiati G, Goldberg SN, lerace T et al. Hepatic metastases, percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology 1997; 205: 367-373
11. Solbiati L, Livraghi T, Goldberg SN et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer, long-term results in 117 patients. Radiology 2001; 221 (1): 159-166
12. deBaere T, Elias D, Dromain C. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Roentgenol 2000; 175: 1619-1625
13. Gewiese B, Beuthan J, Fobbe F et al. Magnetic resonance imaging-controlled laser-induced interstitial thermotherapy. Invest Radiol 1994; 29 (3): 345-351
14. Pech M, Werk M, Beck A et al. Lokalrezidive und Progress nach LITT. Welche MR-Sequenz ist besser? Fortschr Rontgenstr 2004; 176: 550-555
15. Vogl TJ, Muller P, Hirsch H et al. Laser-induced thermotherapy of liver metastases with MRI control. Prospective results of an optimized therapy procedure. Radiologe 1995; 35 (3): 188-199
16. Mack MG, Straub R, Eichler K et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging 2000; 26 (4): 369-374
17. Vogl TJ, Straub R, Eichler K et al. Malignant Liver Tumors Treated with MR Imaging-guided Laser-induced Thermotherapy. Experience with Complications in 899 Patients (2,520 lesions). Radiology 2002; 225 (2): 367-377
18. Tacke J. Perkutane Radiofrequenzablation - klinische Indikationen und Ergebnisse. Fortschr Rontgenstr 2003; 175 (2): 156-168
19. Rhim H. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow: comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2003; 98 (2): 433-434
20. Mulier S, Ni Y, Miao Y et al. Size and geometry of hepatic radiofrequency lesions. Eur J Surg Oncol 2003; 29 (10): 867-878
21. Germer CT, Isbert C, Albrecht D et al. Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model. Ann Surg 1999; 230 (1): 55-62
22. Ricke J, Wust P, Stohlmann A et al. CT-Guided Interstitial Brachytherapy of Liver Malignancies alone or in combination with Thermal Ablation. Phase I/II Results of a Novel Technique. Int J Radiat One Biol Phys 2004; 58: 1496-1505
23. Dritschilo A, Harter KW, Thomas D et al. Intraoperative radiation therapy of hepatic metastases, technical aspects and report of a pilot study. Int J Radiat Oncol Biol Phys 1988; 14 (5): 1007-1011
24. Thomas DS, Nauta RJ, Rodgers JE et al. Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer 1993; 71 (6): 1977-1981
25. McGinn CJ, Ten Haken RK, Ensminger WD et al. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998; 16 (6): 2246-2252
26. Herfarth KK, Debus J, Lohr F et al. Wannenmacher M Stereotactic single dose radiation therapy of liver tumors. Results of a phase I/II trial. J Clin Oncol 2001; 19: 164-170
27. Ricke J, Wust P, Stohlmann A et al. CT-gesteuerte Brachytherapie. Eine neue perkutane Technik zur interstitiellen Ablation von Lebermetastasen. Strahlenther Onkol 2004; 180: 274-280
28. Sullivan RD, Norcross JW, Watkins E. Chemotherapy for metastastic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964; 270: 321-327
29. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30 (5): 969-977
30. Pohlen U, Berger G, Binnenhei M et al. Increased carboplatin concentration in liver tumors through temporary flow retardation with starch microspheres (Spherex) and gelatin powder (Gelfoam). an experimental study in liver tumor-bearing rabbits. J Surg Res 2000; 92 (2): 165-170
31. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984; 2 (5): 498-504
32. Ishikawa H, Kikkawa F, Tamakoshi K et al. Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy. Anticancer Res 1996; 16 (6B): 3849-3853
33. Sileni VC, Fosser V, Maggian P et al. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer. Cancer Chemother Pharmacol 1992; 30 (3): 221-225
34. Schuller J, Czejka MJ, Jager W et al. Comparative bioavailability of fluorouracil and its prodrug, ftorafur, following intra-arterial, intravenous and preoral administration. Pharmazie 1991; 46 (8): 587-588
35. Chang AE, Schneider PD, Sugarbaker PH et al. A prospective randomized trial of regional versus systematic continuous fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-693
36. Martin JK Jr, O'Connell MJ, Wieand HS et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990; 125: 1022-1027
37. Kemeny MM, Goldberg D, Beatty JD et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal cancer. Cancer 1986; 57: 492-498
38. Rougier P, Laplanche A, Huguier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma. Long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-1118
39. Allen-Mersh TG, Earlam S, Fordy C et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-1260
40. Kerr DJ, McArdle CS, Ledermann J et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases. a multicentre randomised trial. Lancet 2003; 361: 368-373
41. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000; 18: 243-254
42. O'Connell MJ, Nagorney DM, Bernath AM et al. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 1998; 16: 2528-2533
43. Kemeny N, Huang Y, Cohen AM et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl JJ Med 1999; 341 (27): 2039-2048
44. Kemeny N, Daly J, Reichman B et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107 (4): 459-465
45. Hohn DC, Stagg RJ, Friedman MA et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to liver, the Northern Oncology Group trial. J Clin Oncol 1989; 7: 1646-1654
46. Herrmann KA, Waggershauser T, Sittek H et al. Liver intraarterial chemotherapy, use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology 2000; 215: 294-299
47. Tanaka T, Arai Y, Inaba Y et al. Radiologic Placement of Side-hole Catheter with Tip Fixation for Hepatic Arterial Infusion Chemotherapy. J Vasc Interv Radiol 2003; 14: 63-68
48. Ricke J, Hildebrandt B, Miersch A et al. Interventional Placement of Hepatic Arterial Port Systems. An Outcome Assessment including different Strategies in Anatomic Variants of the Celiac Branch. J Vasc Interv Radiol 2004; 15: 825-833
49. Tanaka T, Arai Y, Inaba Y et al. Radiologic Placement of Side-hole Catheter with Tip Fixation for Hepatic Arterial Infusion Chemotherapy. J Vasc Interv Radiol 2003; 14: 63-68
50. Wickremesekera JK, Cannan RJ, Stubbs RS. Hepatic artery access ports, recognizing and avoiding the problems. Aust NZ J Surg 2000; 70: 496-502
51. Dizon DS, Kemeny NE. Intrahepatic arterial infusion of chemotherapy, clinical results. Semin Oncol 2002; 29 (2): 126-135
52. Tsalic M, Bar-Sela G, Beny A et al. Severe toxicity related to the 5-fluorouracil/leucovorin combination (the Mayo Clinic regimen): a prospective study in colorectal cancer patients. Am J Clin Oncol 2003; 26: 103-106
53. Vincent M, Ho C, Tomiak A et al. Toxicity analysis of the 5-day bolus 5-fluorouracil/folinic acid regimen for the treatment of colorectal carcinoma from 2 randomized controlled trials, a concern about dose. Clin Colorectal Cancer 2002; 2: 111-118
54. Allen-Mersh TG, Earlam S, Fordy C et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344 (8932): 1255-1260
55. Raoul JL, Heresbach D, Bretagne JF et al. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 1992; 70 (3): 585-590
56. Kruskal JB, Hlatky L, Hahnfeldt P et al. In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors. J Vasc Interv Radiol 1993; 4 (6): 741-747
57. Kameyama M, Imaoka S, Fukuda I et al. Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer. Surgery 1993; 114 (1): 97-101
58. Mavligit GM, Pollock RE, Evans HL et al. Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer 1993; 72 (2): 375-380
59. Therasse E, Breittmayer F, Roche A et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis, adiology 1993; 189 (2): 541-547
60. Stokes KR, Stuart K, Clouse ME. Hepatic arterial chemoembolization for metastatic endocrine tumors. J Vasc Interv Radiol 1993; 4 (3): 341-345
61. Scheele J, Altendorf-Hofmann A, Grube T et al. Resection of colorectal liver metastases. What prognostic factors determine patient selection? Chirurg 2001; 72 (5): 547-560
62. Lambert LA, Colacchio TA, Barth RJ. Interval hepatic resection of colorectal metastases improves patient selection. Curr Surg 2000; 57 (5): 504
63. Livraghi T, Solbiati L, Meloni F et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003; 97 (12): 3027-3035
64. Isbert C, Boerner A, Ritz JP et al. In situ ablation of experimental liver metastases delays and reduces residual intrahepatic tumour growth and peritoneal tumour spread compared with hepatic resection. Br J Surg 2002; 89 (10): 1252-1259
65. Helmberger T, Holzknecht N, Schöpf U et al. Radiofrequenzablation von Lebermetastasen Technik und erste Ergebnisse. Radiologe 2001; 41: 69-76
66. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000; 43 (5): 656-661
67. Livraghi T, Goldberg SN, Solbiati L et al. Percutaneous radio-frequency ablation of liver metastases from breast cancer, initial experience in 24 patients. Radiology 2001; 220: 145-149